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Abstract: Hepatocyte transplantation is being investigated
as a therapy for liver disease; however, its success has been
limited by rapid death of the cells following transplanta-
tion. This study was dedicated to elucidating the mode of
death responsible for loss of transplanted hepatocytes in
order to guide future strategies for promoting their sur-
vival. Using a tissue engineering model, it was found that
the environment within polymer scaffolds containing trans-
planted cells was hypoxic after 5 days in vivo, with (90 6
3)% of hepatocytes existing at pO2 < 10 mmHg. The pri-
mary mode of hepatocyte death in response to hypoxic con-
ditions of 0 or 2 vol % oxygen was then determined in vitro.
Several assays for features of apoptosis and necrosis dem-
onstrated that hepatocytes cultured in an anoxic environ-
ment died via necrosis, while culture at 2% oxygen inhib-
ited proliferation. These results suggest it will not be possi-
ble to prevent hepatocyte death by interfering with the
apoptotic process, and hypoxic conditions in the transplants
must instead be addressed. The finding that the environ-
ment within cell transplantation scaffolds is hypoxic is
likely applicable to many cell-based therapies, and a similar
analysis of the primary mode of death for other cell types
in response to hypoxia may be valuable in guiding future
strategies for their transplantation.  2006 Wiley Periodi-
cals, Inc. J Biomed Mater Res 80A: 520–529, 2007
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INTRODUCTION
Hepatocyte transplantation is a potentially promis-
ing therapy for liver disease; however, this strategy
has been critically limited by the death of a majority
of the transplanted cells within 1 week of their
delivery. The trend of rapid death has been reported
for most tissue engineering approaches to hepatocyte
transplantation, where the cells have been seeded
within constructs to contain them or guide their
growth.1–3 It is hypothesized that the environment
inside such constructs is hypoxic due to isolation
from the recipient’s vasculature, and that this hy-
poxia is a major factor contributing to the hepato-
cytes’ death. Supporting this idea is work from the
field of angiogenesis, which has demonstrated that
tissues more than 100–200 mm away from a blood
vessel become hypoxic, as this is the diffusion limit
for oxygen in most tissues.4 Some hepatocyte trans-
plantation studies have also provided results that
support this hypothesis. When the cell delivery strat-
egy allows for ingrowth of fibrovascular tissue from
the recipient, it has been found that hepatocytes able
to survive the initial post-transplant period go on to
proliferate and survive long-term.5,6 In these studies,
successful engraftment of the transplanted cells has
been attributed to the presence of blood vessels that
grow into the construct and provide oxygen and
other nutrients to the hepatocytes.
In addition to understanding the factors that cause
the loss of transplanted hepatocyte populations, it is
also of interest to elucidate the predominant mode of
death that results. It is unclear whether hepatocytes
undergo necrosis or apoptosis in response to pro-
longed severe hypoxic or anoxic conditions. Most
previous studies of the mode of death in hepatocytes
have been investigations of disease mechanisms (e.g.
hepatitis, cirrhosis, and cholestasis) and of insults to
the cells that are associated with liver transplant pro-
cedures (e.g. ischemia/reperfusion injury, warm vs.
cold perfusion, and storage).7–9 Often, a mixture of
necrosis and apoptosis is reported, with one of the
two mechanisms usually accounting for a majority of
the cell death.7,10,11 However, there has also been
some disagreement over which mode of death is most
significant in similar injury models.11,12 The mecha-
nism of death in response to hypoxia has been inves-
tigated for other cell types, and whether the cells die
predominantly by necrosis or apoptosis appears to
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partially depend upon the identity of the cells. Some
cell types have been shown to upregulate apoptosis
suppressors in response to hypoxia,13 while others
upregulate promoters of apoptosis.14,15
Necrosis and apoptosis differ greatly in the ways
they affect cells, and knowledge of which is predomi-
nant in hepatocytes exposed to hypoxic conditions will
dictate the types of strategies that have the most prom-
ise for enhancing survival. If a majority of hepatocytes
die via apoptosis in response to hypoxia, it may be pos-
sible to prevent their death by interfering with the apo-
ptotic pathway. Errors in regulation of apoptosis have
been shown to be an important component of many
diseases (e.g. cancer, autoimmune diseases, and Alzhei-
mer’s),16,17 and the regulatory mechanisms have thus
been studied extensively to yield knowledge that might
be useful in disease prevention or treatment. Two
groups of proteins that have been found to be particu-
larly important in determining whether a cell will
undergo apoptosis are the Bcl-2 and caspase fami-
lies.18,19 The Bcl-2 family consists of pro-apoptotic (e.g.
Bax, Bad) and anti-apoptotic (e.g. Bcl-2, Bcl-xL) pro-
teins, and studies have demonstrated that it is possible
to inhibit apoptosis by increasing the quantity of anti-
apoptotic members within the cell.10,20 There are also
two groups within the caspase family: initiator cas-
pases, which activate the second group, the effector
caspases, which are responsible for cleaving proteins
that eventually result in cell death.21,22 Inhibiting mem-
bers of the caspase family has been demonstrated to
prevent apoptosis as well.23–25 These methods could
potentially be useful in enhancing transplanted hepato-
cyte survival, but only if the dominating mode of death
is apoptosis. If, on the other hand, necrosis is the major
form of death experienced by hepatocytes in hypoxia,
there is not a specifically regulated pathway with
which to interfere. Instead, it will be critical to focus on
alleviating hypoxia at the transplant site, and otherwise
enhancing conditions to promote hepatocyte survival.
In this study, the existence of hypoxic conditions
within scaffolds used for hepatocyte transplantation was
first investigated to confirm that the cells are indeed
exposed to hypoxia upon transplantation. Experiments
were then performed in which hepatocytes were cul-
tured in a hypoxic environment and assayed to deter-
mine the mode of death that occurs. The results of this
investigation promise to help guide strategies for pro-
moting transplanted hepatocyte survival in the future.
MATERIALS AND METHODS
Scaffold fabrication
Scaffolds were formed using a modification of a previ-
ously published process,26,27 which involves fabricating poly-
lactide-co-glycolide (PLG) into microspheres prior to forming
scaffolds from the polymer. Microspheres were made using
85:15 PLG (85:15 high i.v. Medisorb, Alkermes; Cambridge,
MA) via a standard double emulsion process.28 In brief, a
5% (w/v) solution of PLG in ethyl acetate (EtAc) (Sigma, St.
Louis, MO) was combined with distilled, deionized water in
a test tube. This two-phase mixture was then sonicated to
yield a single emulsion. An equal volume of an aqueous so-
lution containing 1% polyvinyl alcohol (PVA; MW 25,000;
88% hydrolyzed; Polysciences Inc., Warrington, PA) and 7%
EtAc was added to the single emulsion, and the resulting
solution was vortexed (Vortex Genie, VWR) to yield the
double emulsion. This double emulsion was immediately
transferred to a rapidly stirring aqueous solution of 0.3%
PVA/7% EtAc. After allowing the EtAc to evaporate over a
3-h period, the microsphere-containing solution was filtered
to retrieve the microspheres, which were then rinsed with
distilled water, flash frozen, and lyophilized.
For each scaffold, 3 mg of microspheres were combined
with 150 mL of a 0.1% MVM alginate (Pronova, Oslo, Nor-
way) solution. This mixture was lyophilized to form a
powder, combined with 50 mg NaCl (sieved to yield a par-
ticle diameter between 250 and 425 mm), and pressed in a
4.763 mm diameter die to create a 1.5 mm thick disk. The
PLG was gas foamed by subjecting the disks to 800 psi
CO2 for 24 h, followed by a rapid reduction of pressure to
ambient. The NaCl was leached from scaffolds by incubat-
ing in 0.1M CaCl2 for 16 h prior to use in experiments.
Scaffolds were sterilized by soaking in 100% ethanol for
20 min, followed by five 5-min washes with sterile PBS.
Hepatocyte isolation
Hepatocytes were isolated from adult male Lewis rats (150–
200 g, Charles River Breeding Laboratories, Wilmington, MA)
with a modification of the original Seglen two-step collagenase
perfusion procedure.29 Briefly, the liver was perfused via the
portal vein, first with calcium free buffer (142 mM NaCl, 7 mM
KCl, 20 mM Hepes, pH 7.4, and 378C) for 10 min, followed im-
mediately by collagenase containing buffer (142 mM NaCl,
7 mM KCl, 20 mM CaCl2, 20 mM Hepes, 0.5 mg/mL Collage-
nase Type 2 (Worthington Biochemical), pH 7.4, and 378C). Per-
fusion with the collagenase-containing buffer was continued for
7–10 min. The perfused liver was then placed in ice-cold Wil-
liam’s Medium E, and cells were dissociated by removing the
liver capsule, and gently shaking the hepatocytes free from the
remaining liver matrix. This cell suspension was filtered
through a 400 mm Nytex mesh (Tetko Inc., Elmsford, NY) to
remove large debris. The cell yield per liver was 1–2  108 and
the initial percentage of viable cells was 80–90%. To further
purify the cell population and remove cellular debris, density
gradient centrifugation using Percoll (Sigma) was performed.
The collected hepatocytes, which had a total cell viability greater
than 90%, were then placed on ice and immediately used in
experiments. NIH guidelines for the care and use of laboratory
animals (NIH Publication No. 85-23 Rev. 1985) were observed
throughout this study.
SCID mouse implants
Immediately before matrix implantation, 1  106 hepato-
cytes were suspended in 25 mL of a 1:1 mixture of Wil-
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liam’s Medium E and growth factor reduced Matrigel1
(BD Biosciences, Bedford, MA), and allowed to absorb into
the polymer scaffolds for 5 min. The cell seeding efficiency
was determined by counting the cells remaining in the
dish after this absorption period.
Scaffolds (n ¼ 4) were implanted in subcutaneous pockets
(2 per animal) on the dorsal region of 7–9 week old male
SCID mice (cb17/SCID) (Taconic Labs, Germantown, NY). A
1.5 cm longitudinal incision was made on the animal’s back
and the tips of dissecting scissors were slipped under the
skin, between the skin and muscle layers, and opened
slowly to create spaces into which the implants could be
placed. One implant was then placed on either side of the
incision, and the incision was closed with two interrupted
sutures and covered with tissue adhesive (Mastisol, Ferndale
Labs; Ferndale, MI) to help seal the opening. All NIH guide-
lines for the care and use of laboratory animals (NIH Publi-
cation No. 85-23 Rev. 1985) were observed.
Femoral artery ligation
Ligation of the femoral artery was performed on the left
hind limb of mice three days after they received hepatocyte-
seeded matrices. Animals were anesthetized and a 1 cm inci-
sion was created along the contour between the hindlimb
and body of the mouse. Dissecting forceps were then used
to tease away the exposed tissue to reveal the femoral artery
and vein. Two suture knots were tied around both the artery
and vein 5 mm apart, and both vessels were severed
between the sutures. The incision was then closed with two
interrupted sutures and covered with tissue adhesive.
Hypoxyprobe injection and histology
HypoxyprobeTM (Chemicon, Temecula, CA) was used to
detect hypoxic tissue regions within the transplanted scaf-
folds. Muscle tissue surrounding the area of the femoral ar-
tery ligation served as a positive control for tissue hypoxia,
while muscle tissue from the non-operated hind limb served
as a negative control. Five days after scaffold implantation
(2 days after femoral artery ligation), mice were intraperito-
neally injected with 100 mL of a 15 mg/mL solution of
Hypoxyprobe. Animals were killed 1 h later to retrieve scaf-
folds and obtain samples of muscle tissue from each hind
limb. The dissected tissues were immediately placed into
10 mL of buffered zinc-formalin, where they remained for
24 h at 48C. The zinc-formalin was then exchanged for 70%
ethanol and samples were stored at 48C until they were em-
bedded in paraffin, sectioned, and mounted on glass slides
by the University of Michigan, School of Dentistry Histology
Core. Immunostaining for the presence of Hypoxyprobe
adducts within the tissue was performed according to the
protocol included with the product. To quantify the percent-
age of hepatocytes existing in hypoxic conditions, positively
and negatively stained cells in sections of each scaffold were
counted at 200 magnification.
Hepatocyte culture
For in vitro studies, hepatocytes were cultured in a
defined medium of Williams’ Medium E (Invitrogen Life
Technologies, Carlsbad, CA) supplemented with sodium
pyruvate (20 mM; Sigma), ascorbic acid (500 ug/mL;
Sigma), insulin (5 mg/mL), transferrin (5 mg/mL), selenium
(5 ng/mL; ITS supplement, Sigma), dexamethasone (5 nM;
Sigma), EGF (10 ng/mL; Peprotech, Inc., Rocky Hill, NJ),
and penicillin–streptomycin (100 U/mL; Invitrogen Life
Technologies). The cells were cultured in 6-well tissue cul-
ture plates coated with 1 mg/cm2 of type 1 bovine collagen
(Vitrogen, Cohesion Palo Alto, CA). Collagen coating was
performed by diluting the stock collagen solution to a con-
centration of 4.3 mg/mL in carbonate/bicarbonate buffer
(15 mM sodium carbonate, 35 mM sodium bicarbonate,
pH 9.4 with glacial acetic acid), aliquoting 3 mL of this so-
lution per well, and incubating overnight at 48C. Wells
were rinsed with PBS prior to cell seeding.
Hepatocytes were seeded in prepared plates immedi-
ately after isolation, at a density of 2.6  104 cells/cm2 of
culture area. Before the cells were subjected to hypoxic cul-
ture conditions, they were allowed 36 h to adapt to culture
under typical conditions (378C, 5% CO2, 20% O2). To create
hypoxic conditions, the culture plates were placed in a
modular incubator chamber (Billups-Rothenberg, Inc, Del
Mar, CA), which was then flushed with a mixture of either
2% O2, 5% CO2, 93% N2, or 0% O2, 5% CO2, 95% N2 (vol %)
(Cryogenic Gases, Detroit, MI). Incubator chambers were
sealed and placed in a traditional incubator at 378C. After
1 h, the chambers were reflushed with the gas mixture
to remove ambient gases that may have been trapped in
the tissue culture plates. Chambers were also reflushed at
12-h intervals during the culture period, and after medium
changes.
Monitoring cell number and survival
To initially determine the effect of hypoxic conditions
on hepatocyte survival and proliferation, changes in cell
number were monitored. Hepatocytes were cultured as
described earlier in 0, 2, or 20% oxygen and assayed for
cell number just prior to initiating hypoxic culture, and
then at 24, 48, and 72 h afterwards. Changes in total cell
number were determined by combining both adherent and
floating cells from triplicate samples, and counting them in
a model ZM Coulter Counter. For other samples, only ad-
herent hepatocytes were counted to assess the number of
cells that were still capable of attaching to the culture sur-
face. To further examine the effect of hypoxia on cell sur-
vival, adherent and floating cells were combined and
assayed for their ability to exclude trypan blue. Trypan
blue solution (Sigma) was added to the cell suspension at
a volume ratio of 1:10. After a 2-min incubation, four ran-
dom fields of cells were counted at 200 magnification to
determine the live and dead fractions.
Annexin V and propidium iodide labeling
Hepatocytes exposed to hypoxic conditions were as-
sayed for membrane permeability and externalization of
phosphatidyl serine by incubating the cells with propi-
dium iodide and annexin V-EGFP, which binds to extracel-
lular phosphatidyl serine (ApoAlert Apoptosis detection
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kit; BD Biosciences, Palo Alto, CA). The cells were cultured
in 0, 2, or 20% oxygen, and were analyzed 6 and 12 h after
initiating hypoxic conditions. For each sample, 2  105
cells were rinsed with PBS and incubated in the dark for
15 min with Annexin V-EGFP and propidium iodide
(ApoAlert kit). The cells were then visualized under a flu-
orescence microscope using filter settings for FITC and
rhodamine to visualize annexin V-EGFP and propidium
iodide, respectively. Three random microscope fields of
cells from triplicate samples were photographed on both
brightfield and fluorescent settings, and total cell number
and positively stained cell number were counted to deter-
mine the fraction of cells staining positive for each marker.
Fluorometric assay of caspase-3 activity
The presence of active caspase-3 in hepatocyte cultures
was determined using an established fluorometric assay.30
Cells were exposed to 0 or 2% oxygen for 24, 48, or 72 h
and cells cultured in 20% oxygen served as a control for
background caspase-3 activity. Attached cells were trypsi-
nized and combined with floating cells, for a total of 3 
105 hepatocytes per sample (triplicate samples were col-
lected for each condition). In brief, the cells were rinsed
with PBS, placed at 808C for 5 min, and then incubated
in lysis buffer (50 mM HEPES, 1 mM DTT, 0.1 mM EDTA,
0.1% CHAPS, and pH 7.4) for 45 min on ice. When lysis
was complete, samples were centrifuged and the superna-
tant cell extract was collected. For each sample, 20 mL of
cell extract was combined with assay buffer (100 mM
NaCl, 50 mM HEPES, 10 mM DTT, 1 mM EDTA, 10%
glycerol, 0.1% CHAPS) in a 96-well plate. Finally, the fluo-
rogenic caspase-3 substrate, Ac-DEVD-AMC (Alexis Bio-
chemicals, San Diego, CA), was added to all wells, and the
plate was placed in a fluorometer (GENios; TECAN, Grö-
dig, Austria) with the temperature maintained at 378C.
DEVDase activity was monitored over the course of 3 h at
excitation and emission wavelengths of 360 and 460 nm,
respectively. Purified recombinant human caspase-3
(Alexis) was used as a positive control, and the caspase-3
inhibitor Ac-DEVD-CHO (Alexis) was used to control for
nonspecific cleavage of the fluorogenic substrate.
Analysis of DNA degradation
To isolate and analyze DNA from cultured hepatocytes,
a DNA isolation kit was used (Suicide-Track, CalBiochem,
San Diego, CA). Again, cells were exposed to 0 or 2% oxy-
gen for 24, 48, or 72 h, and cells cultured in normoxia
(20%) served as negative controls. The positive control was
supplied with the kit, and consisted of a pellet of HL60
cells that had been treated with actinomycin D for 19 h.
Both attached and floating cells were harvested for all con-
ditions, and total DNA was isolated according to the kit
instructions from 8  105 cells for each sample. To visu-
alize the pattern of DNA degradation, samples were mixed
with loading buffer (supplied with kit) and ethidium bro-
mide and run on a 1.5% agarose gel in 1 TAE buffer
(50 TAE stock, 242 g/L Tris base; 100 mL/L 0.5M EDTA;
pH 8.0; 57.1 mL/L glacial acetic acid) at 50 constant volts
Figure 1. Photomicrographs of hypoxyprobe stained
muscle tissue and hepatocyte-containing scaffold. Muscle
tissue from hindlimb with ligated femoral artery served as
the positive control for hypoxia (A) and tissue from the
other hindlimb served as the negative control (B). Trans-
planted scaffolds containing hepatocytes are largely hy-
poxic as indicated by positive hypoxyprobe staining through-
out a majority of the tissue sections (C). Original magnifica-
tion was 400. [Color figure can be viewed in the online
issue, which is available at www.interscience.wiley.com.]
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for 2.5 h. Gels were illuminated with UV light and pho-
tographed using a Polaroid GelCam.
RESULTS
Evaluation of hypoxia at transplant site
To determine whether the transplant site was a hy-
poxic environment, a solution of pimonidazole hydro-
chloride, which forms adducts with thiol groups
in proteins only under hypoxic conditions (pO2 <
10 mmHg) was infused into animals receiving hepato-
cyte transplants. Primary rat hepatocytes were first
seeded onto PLG scaffolds, with a seeding efficiency
of (49 6 6)%, and implanted subcutaneously in SCID
mice. Three days after receiving implants, mice had
their left femoral artery ligated to provide hypoxic
muscle tissue as a positive control. Two days after the
ligation was performed, mice were injected with a so-
lution of pimonidazole hydrochloride and sacrificed
1 h later for retrieval of implants and control tissues.
Immunostaining of muscle tissue from the operated
and non-operated hind limbs (i.e. the positive and
negative control, respectively) confirmed the accuracy
of this system in detecting hypoxic tissue regions [Fig.
1(A,B)]. Observation of immunostained hepatocyte-
containing scaffolds revealed that the environment
within the scaffolds was significantly hypoxic [Fig.
1(C)]. Quantification of positively and negatively stained
hepatocytes indicated that (90 6 3)% of the transplanted
cells were positive for hypoxia.
Changes in cell number and survival
To initially assess the effect of hypoxic conditions
on hepatocytes, these cells were cultured with 0, 2, or
20% oxygen and monitored for changes in the num-
ber of total cells (adherent and floating) over the
course of 72 h. The total cell number [Fig. 2(A)] re-
mained approximately constant for all conditions
24 h after initiating hypoxic culture, but significant
differences became apparent at the 48 h time point. In
the 0% oxygen condition, hepatocyte numbers had
decreased to nearly half the initial value, while the
cell numbers in 2% oxygen increased slightly and the
population of cells at normoxia increased by about
65%. The values for 2 and 20% oxygen remained sim-
ilar at 72 h, but there was an additional decrease in
cell number for the anoxic condition. Analysis of only
adherent cells revealed a similar trend for the 2 and
20% culture conditions, as most of these cells re-
mained attached to the plates [Fig. 2(B)]. The number
of adherent cells for 0% oxygen decreased with time,
as did the total number of cells; however, the decline
was more rapid and significant when only adherent
cells were counted, confirming observations of cell
detachment in this condition. Finally, the survival of
hepatocytes in all conditions was assessed by the
cells’ ability to exclude trypan blue [Fig. 2(C)]. The
fraction of surviving cells growing in normal condi-
tions remained approximately constant throughout
the culture time, decreasing only slightly at the last
time point. Culture in 2% oxygen led to a minor de-
crease in survival, compared with the normoxia con-
trol condition. Anoxic conditions resulted in a signifi-
cant decline in hepatocyte survival, as only about
10% of the cells were able to exclude trypan blue after
24 h, and all cells were dead by 72 h.
Annexin V/propidium iodide labeling
Hepatocytes exposed to hypoxic conditions for 6 or
12 h were assayed for annexin V binding, an early in-
dicator of apoptosis, and membrane permeability to
propidium iodide, an indicator of necrosis or late ap-
optosis. Very few cells in any of the conditions were
positive for annexin V binding; cells that did label
with annexin V tended to be floating and were also
Figure 2. Changes in total hepatocyte number (A), adherent cell number (B), and survival as determined by trypan
blue exclusion over time in cultures (C). Culture in 0% oxygen (white) caused significant declines in cell number and sur-
vival (p < 0.05). In contrast, culture in 2% oxygen (grey) led to inhibited proliferation as compared to normoxic control
(black) (p < 0.05), and had an insignificant effect on survival.
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labeled positively with propidium iodide, suggesting
that apoptosis was not occurring (Fig. 3). Analysis
was therefore focused on observation and quantifica-
tion of propidium iodide positive cells. Analysis of
the cells via fluorescence microscopy revealed that at
both 6 (images not shown) and 12 h (Fig. 4), a signifi-
cant portion of hepatocytes exposed to 0% oxygen
were positive for propidium iodide. In contrast, there
were only a small number of propidium iodide-posi-
tive cells in the 2 and 20% oxygen conditions. Quanti-
fication of the propidium iodide labeling demon-
strated an increase in membrane permeability over
time for cells cultured under anoxia, with (53 6 13)%
and (70 6 8)% of cells positive after 6 and 12 h in 0%
oxygen, respectively. Less than 1% of cells cultured in
2 or 20% oxygen were positive for propidium iodide
at both time points.
Assay of caspase 3 activity
Activation of caspase-3 was investigated using a
fluorometric assay in cells subjected to the experi-
mental conditions for 24, 48, and 72 h. The cell ex-
tracts analyzed in the assay were obtained from ap-
proximately the same number of hepatocytes for each
sample to allow for direct comparison between condi-
tions. Plots of fluorescence intensity versus time were
created for each sample, and curves were also inte-
grated to provide an estimate of total fluorescence
measured over the course of the assay. Fluorescence
intensity increased with time for all samples (except
for samples where caspase-3 inhibitor was added)
because of accumulation of fluorescent product after
cleavage by caspase-3 (Fig. 5). However, none of the
samples cultured with low oxygen demonstrated
enhanced caspase-3 activity above that of the negative
control samples cultured in normal conditions. Integrat-
Figure 4. Fluorescent images of adherent hepatocytes
incubated with annexin V and propidium iodide (red fluo-
rescence) after culture in 0% (A), 2% (B) or 20% (C) oxygen
for 12 h. Cells were growing in a confluent monolayer in
all conditions. The 0% oxygen environment led to a
marked increase in the fraction of cells that became labeled
with propidium iodide. Original magnification 200.
[Color figure can be viewed in the online issue, which is
available at www.interscience.wiley.com.]
Figure 3. Fluorescent images of hepatocytes that had
detached from the culture surface after 6 h of culture in 2%
oxygen demonstrate positive staining for both annexin V (A)
and propidium iodide (B). These results are indicative of
those for floating cells in all conditions. Original magnifica-
tion 400. [Color figure can be viewed in the online issue,
which is available at www.interscience.wiley.com.]
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ing the curves to determine total fluorescence for each
sample illustrates this trend more clearly (Fig. 6). It is
also evident that there was actually a slight decrease in
caspase-3 activity for hepatocytes cultured in 2% oxy-
gen for 72 h, and a more dramatic, significant decrease
for cells cultured in 0% oxygen for 48 and 72 h. The
general lack of fluorescence measured in samples in
which caspase-3 inhibitor was added confirms the spec-
ificity of substrate cleavage by caspase-3. Fluorescence
intensity measured for the positive control of purified
caspase-3 indicated the functionality of the assay.
Analysis of DNA degradation
The pattern of DNA degradation in hepatocytes
exposed to hypoxic conditions for varying amounts
of time was measured to determine whether it was
characteristic of necrosis or apoptosis. After 24 h of
exposure to hypoxia there was no apparent degrada-
tion of DNA, and the 0 and 2% oxygen samples
looked identical to the negative controls cultured in
normoxia (not shown). When cells were exposed to
experimental conditions for 48 and 72 h, however,
DNA degradation that was nonspecific in nature
became apparent for cells cultured in anoxia (Fig. 7).
Even at these longer time points there was no evi-
Figure 5. Caspase-3 activity as measured by fluorogenic
substrate cleavage over time. (A) The positive control of
1 ng purified caspase-3 indicates effectiveness of the assay.
(B) Samples from experimental hypoxic conditions did not
exhibit enhanced caspase-3 activity above that for the nor-
moxic control.
Figure 6. Total caspase-3 activity measured over assay
time, as determined by integrating curves of fluorescence
versus time, for cells incubated in the various conditions
for 24 (black), 48 (grey), or 72 (white) h. Values are nor-
malized to the 20% oxygen condition at the same time
point.
Figure 7. DNA isolated from hepatocytes exposed to
hypoxic culture conditions for 48 and 72 h. A positive con-
trol (þ) for apoptosis demonstrating characteristic DNA
ladder and molecular weight marker (M) are also included
for reference.
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dence of DNA degradation in samples exposed to 2%
oxygen, and they remained similar in appearance to
samples from normal culture conditions.
DISCUSSION
The results of this in vivo study confirmed that
hypoxic conditions exist within three-dimensional
constructs used for hepatocyte transplantation, and
in vitro studies indicated that hepatocytes’ mode of
death in response to hypoxia is necrosis. Knowledge
of the mechanism of death in transplanted cells may
provide insight regarding effective methods to pre-
vent their death in subsequent studies.
Analysis of hepatocytes transplanted subcutane-
ously to SCID mice within PLG scaffolds revealed
that the cells’ environment was hypoxic for the 5 days
of the study. Immunohistochemical analysis of re-
trieved implants showed that 90% of the trans-
planted cells were in an environment with a partial
pressure of oxygen below 10 mmHg (1% vol %
oxygen). The small fraction of non-hypoxic cells was
localized at the outer edges of the implants. This
result is not surprising, as it has been generally ac-
cepted that the environment of such three-dimen-
sional constructs initially provides insufficient oxygen
and other nutrients, due to isolation from the blood
supply.31 Although expected, this result is significant
in that it confirms the existence of hypoxia within the
cell delivery constructs.
Several assays indicated that exposure of hepato-
cytes to 2% oxygen did not significantly induce cell
death, while anoxic culture led to death via necrosis.
Measurement of cell numbers over time demon-
strated that culture in 0% oxygen killed a majority of
hepatocytes within 2–3 days, and 2% oxygen slightly
inhibited proliferation but did not cause cell death
over the same time period. Measurements of cell via-
bility using the trypan blue exclusion assay were con-
sistent with the cell number assay. Permeabilization
of the cell membrane is an indicator of necrosis, but it
also occurs in the end stages of apoptosis.32 Hepato-
cytes incubated with annexin V and propidium
iodide did not exhibit significant annexin V binding
in any samples after 6 or 12 h in the experimental cul-
ture conditions. However, a majority of cells from the
0% oxygen condition were positive for propidium
iodide after 6 h, and more were positive after 12 h.
The lack of annexin V binding indicates that phos-
phatidyl serine was not exposed on the outer leaflet
of the plasma membrane, which suggests that apo-
ptosis is not occurring, as phosphatidyl serine misloc-
alization is one of the earliest phenomena of apopto-
sis.33,34 In contrast, the propidium iodide staining of
the anoxic cells demonstrates compromised mem-
brane integrity, confirming results from the trypan
blue assay, and indicates necrosis as the mode of
death. Elevated caspase-3 activity, another early indi-
cator of apoptosis, was not detected in extracts from
hepatocytes cultured in 0 or 2% oxygen for 24, 48, or
72 h, indicating an absence of the apoptotic process.
In fact, a significant decrease in caspase-3 activity
was observed in samples from cells that had been
maintained in 0% oxygen for 48 and 72 h. This
decline is likely due to proteolysis and cytoplasmic
leakage associated with necrotic death. Finally, hepa-
tocytes cultured in 0% oxygen for 48 or 72 h exhibited
nonspecific DNA degradation consistent with necro-
sis. During apoptosis, DNA is specifically degraded
by endonucleases only between nucleosomes, leaving
fragments that are multiples of 180 base pairs.32
When electrophoresed on a gel these fragments create
a characteristic ladder-like pattern, whereas necrotic
DNA creates a nonspecific smear like that evidenced
by the hepatocytes cultured in anoxia. Investigations
of hepatocytes cultured in anoxic conditions are not
prevalent in the literature; however, at least one other
group has observed necrosis of anoxic hepatocytes
in vitro.35,36 Ischemic hepatocytes have also been dem-
onstrated to die primarily via necrosis in a study
where fragments of rat liver were left in the perito-
neal cavity of other rats for several days.37
Interestingly, hepatocytes cultured at 2% oxygen
were resistant to death, although this degree of hy-
poxia did reduce proliferation of the cells. Hepato-
cytes in the liver exist along an oxygen gradient
within hexagonal subunits of the organ known as
lobules,38 and there exists a subpopulation of hepato-
cytes that are adapted to survival in a relatively oxy-
gen-poor environment (corresponding to 4 vol %).
Proliferation of the cells in this study was slowed at
2% oxygen, and metabolic activity was likely affected
by this level of hypoxia.39,40 It is encouraging that he-
patocytes seem able to survive relatively in low oxy-
gen levels, suggesting that even a slight improvement
of oxygen transport at the transplant site may have a
positive affect.
If other cell types are observed to undergo apopto-
sis in response to hypoxic conditions in future inves-
tigations, it may be possible to prevent their death by
interfering with one or more mechanisms of the apo-
ptotic process, as mentioned previously. Specifically,
retroviral- or adenoviral-mediated gene transfer tech-
niques could be used to cause the cells to overexpress
an apoptotic suppressor, such as Bcl-2 or Bcl-xL.10,20
The survival of these genetically altered cells could
then be monitored with both in vitro and in vivo
studies. Another potential approach, which would be
most applicable for in vitro investigation, involves
exposing the cells to molecules that inhibit caspase
activity to stop the apoptotic pathway, for example,
caspases 3 and 9 are inhibited by the molecules
Ac-DEVD-CHO and z-LEHD-FMK, respectively.24 To
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prevent apoptosis, cells could also be cultured under
hypoxic conditions on surfaces coated with fibronec-
tin or laminin, as cellular adhesion to these extracellu-
lar matrix molecules has been demonstrated to sup-
press apoptotic death in a number of reports.41–43
Further, lack of enhanced survival when cells are cul-
tured on these ECM molecules could be taken as an
indication that apoptosis is not a primary mechanism
of cell death, and that apoptosis prevention will not
enhance survival. Primary rat hepatocytes have pre-
viously been observed to secrete and assemble a sig-
nificant fibronectin matrix within 30 h of initiating se-
rum-free culture.44 This time-frame correlates well
with the 36 h pre-culture period used in the current
study before initiation of anoxia, and the hepatocytes
in the present study were thus likely in contact with a
fibronectin-enriched extracellular matrix. This sug-
gests that interfering with apoptosis via ECM effects
will not prevent hepatocyte death in anoxic condi-
tions.
The results of this work have important implica-
tions for enhancing the survival of hepatocytes and
other cells transplanted in tissue engineering strat-
egies. It will likely be critical to alleviate the hypoxia
as quickly as possible to prevent massive death of the
cells. In this investigation it was also found that hepa-
tocytes die via necrosis, not apoptosis, in response to
anoxic conditions in vitro, suggesting that future
efforts should be focused upon rapid reduction of hy-
poxia at the transplant site and creation of an envi-
ronment that promotes hepatocyte survival in ways
(e.g. provision of appropriate extracellular matrix,
growth factors, hormones) other than interference
with apoptosis. Since the mode of death resulting
from a given stimulus varies with cell type, efforts to
inhibit apoptosis may be effective in addressing the
initial loss of other transplanted cell populations.
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